Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epiduo Application Education vs BPO in Acne
NCT02192632Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2014
- Primary completion
- Feb 2015
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of adapalene + benzoyl peroxide in acne vulgaris (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Percentile reduction of non-inflammatory & inflammatory acne lesions at 12 weeks. Started Jan 2014; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02192632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192632.